Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.

Article  PubMed  Google Scholar 

Bates SE. Epigenetic therapies for Cancer. N Engl J Med. 2020;383:650–63.

Article  CAS  PubMed  Google Scholar 

Li Y, Liu HT, Chen X, et al. Aberrant promoter hypermethylation inhibits RGMA expression and contributes to tumor progression in breast cancer. Oncogene. 2022;41:361–71.

Article  CAS  PubMed  Google Scholar 

Usui G, Matsusaka K, Mano Y, Urabe M, Funata S, Fukayama M, Ushiku T, Kaneda A. DNA methylation and genetic aberrations in gastric Cancer. Digestion. 2021;102:25–32.

Article  CAS  PubMed  Google Scholar 

Takeuchi C, Yamashita S, Liu YY, et al. Precancerous nature of intestinal metaplasia with increased chance of conversion and accelerated DNA methylation. Gut. 2024;73:255–67.

Article  CAS  PubMed  Google Scholar 

Kuang Y, He Z, Li L, et al. The developmental regulator HAND1 inhibits gastric carcinogenesis through enhancing ER stress apoptosis via targeting CHOP and BAK which is augmented by cisplatin. Int J Biol Sci. 2023;19:120–36.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yu JC, Zhou H, Bai J, Yu Y, Geng JS, Qi JP, Fu SB. Human gastric adenocarcinoma allelotype on chromosomes 17 and 18. J Int Med Res. 2008;36:279–88.

Article  CAS  PubMed  Google Scholar 

Yu JC, Sun KL, Liu B, Fu SB. Allelotyping for loss of heterozygosity on chromosome 18 in gastric cancer. World J Gastroenterol. 2004;10:1964–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yuan X, Piao L, Wang L, Han X, Zhuang M, Liu Z. Pivotal roles of protein 4.1B/DAL–1, a FERM–domain containing protein, in tumor progression (review). Int J Oncol. 2019;55:979–87.

CAS  PubMed  Google Scholar 

Chen X, Guan X, Zhang H, Xie X, Wang H, Long J, Cai T, Li S, Liu Z, Zhang Y. DAL-1 attenuates epithelial-to mesenchymal transition in lung cancer. J Exp Clin Cancer Res. 2015;34:3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Heller G, Geradts J, Ziegler B, Newsham I, Filipits M, Markis-Ritzinger EM, Kandioler D, Berger W, Stiglbauer W, Depisch D, Pirker R, Zielinski CC, et al. Downregulation of TSLC1 and DAL-1 expression occurs frequently in breast cancer. Breast Cancer Res Treat. 2007;103:283–91.

Article  CAS  PubMed  Google Scholar 

Dafou D, Grun B, Sinclair J, Lawrenson K, Benjamin EC, Hogdall E, Kruger-Kjaer S, Christensen L, Sowter HM, Al-Attar A, Edmondson R, Darby S, et al. Microcell-mediated chromosome transfer identifies EPB41L3 as a functional suppressor of epithelial ovarian cancers. Neoplasia. 2010;12:579–89.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bernkopf DB, Williams ED. Potential role of EPB41L3 (protein 4.1B/Dal-1) as a target for treatment of advanced prostate cancer. Expert Opin Ther Targets. 2008;12:845–53.

Article  CAS  PubMed  Google Scholar 

Zhang S, Guo M, Guo T, Yang M, Cheng J, Cui C, Kang J, Wang J, Nian Y, Ma W, Weng H, Weng H. DAL-1/4.1B promotes the uptake of exosomes in lung cancer cells via Heparan Sulfate Proteoglycan 2 (HSPG2). Mol Cell Biochem. 2022;477:241–54.

Article  CAS  PubMed  Google Scholar 

Gu Y, Chu C, Yuan B, Wang J, Pan S. Expression and hypermethylation of JAM and EPB41L3 in cervical squamous cell carcinoma: clinical significance and applications. Histol Histopathol. 2024;39:1043–51.

PubMed  Google Scholar 

Liu Y, Yu K, Kong X, et al. FOXA1 O-GlcNAcylation-mediated transcriptional switch governs metastasis capacity in breast cancer. Sci Adv. 2023;9:eadg7112.

Article  PubMed  PubMed Central  Google Scholar 

Guo H, Zhang R, Afrifa J, Wang Y, Yu J. Decreased expression levels of DAL-1 and TOB1 are associated with clinicopathological features and poor prognosis in gastric cancer. Pathol Res Pract. 2019;215:152403.

Article  CAS  PubMed  Google Scholar 

Goldman MJ, Craft B, Hastie M, Repecka K, McDade F, Kamath A, Banerjee A, Luo Y, Rogers D, Brooks AN, Zhu J, Haussler D. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38:675–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

UniProt C. UniProt: the Universal protein knowledgebase in 2023. Nucleic Acids Res. 2023;51:D523–31.

Article  Google Scholar 

Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, Gable AL, Fang T, Doncheva NT, Pyysalo S, Bork P, Jensen LJ, et al. The STRING database in 2023: protein–protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51:D638–46.

Article  CAS  PubMed  Google Scholar 

Oughtred R, Rust J, Chang C, Breitkreutz BJ, Stark C, Willems A, Boucher L, Leung G, Kolas N, Zhang F, Dolma S, Coulombe-Huntington J, et al. The BioGRID database: a comprehensive biomedical resource of curated protein, genetic, and chemical interactions. Protein Sci. 2021;30:187–200.

Article  CAS  PubMed  Google Scholar 

Kumar V, Ramnarayanan K, Sundar R, Padmanabhan N, Srivastava S, Koiwa M, Yasuda T, Koh V, Huang KK, Tay ST, Ho SWT, Tan ALK, et al. Single-cell atlas of Lineage States, Tumor Microenvironment, and subtype-specific expression programs in gastric Cancer. Cancer Discov. 2022;12:670–91.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li C, Wong WH. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci U S A. 2001;98:31–6.

Article  CAS  PubMed  Google Scholar 

Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, Nery JR, Lee L, Ye Z, Ngo QM, Edsall L, Antosiewicz-Bourget J, et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature. 2009;462:315–22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dickey BL, Nedjai B, Preece MD, et al. Methylation of HPV16 and EPB41L3 in oral gargles and the detection of early and late oropharyngeal cancer. Cancer Med. 2022;11:3735–42.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Giuliano AR, Nedjai B, Lorincz AT, et al. Methylation of HPV 16 and EPB41L3 in oral gargles: associations with oropharyngeal cancer detection and tumor characteristics. Int J Cancer. 2020;146:1018–30.

Article  CAS  PubMed  Google Scholar 

Tuerxun G, Li W, Abudurexiti G, Zhuo Q, Tuerdi A, Abulizi G. EPB41L3 inhibits the progression of Cervical Cancer Via the ERK/p38 MAPK signaling pathway. Mol Biotechnol Published Online June 21, 2024.

Ma X, Liu J, Wang H, et al. Identification of crucial aberrantly methylated and differentially expressed genes related to cervical cancer using an integrated bioinformatics analysis. Biosci Rep. 2020;40:BSR20194365.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guan XY, Fu SB, Xia JC, Fang Y, Sham JS, Du BD, Zhou H, Lu S, Wang BQ, Lin YZ, Liang Q, Li XM, et al. Recurrent chromosome changes in 62 primary gastric carcinomas detected by comparative genomic hybridization. Cancer Genet Cytogenet. 2000;123:27–34.

Article  CAS  PubMed  Google Scholar 

Wang Q, Wang B, Guan X, Gao H, Cheng H, Zhang Q, Huang C, Li P, Fu S. Analysis of comparative genomic hybridization and loss of heterozygosity in 43 primary gastric carcinomas. Chin Med J (Engl). 2003;116:517–23.

CAS  PubMed  Google Scholar 

Nishiyama A, Nakanishi M. Navigating the DNA methylation landscape of cancer. Trends Genet. 2021;37:1012–27.